Figure 1.

Overview of the participants whose nasal swabs were included in the analysis. ^aSymptoms not required for participation. ^bMedication exclusion list: metformin, insulin, cimetidine, hydroxychloroquine, sulfonylurea, dolutegravir, dolutegravir, patiromir, ranalazine, tafenoquine, ivennectin, sodium picosulfate, lithium, valproate, fluvoxamine, rasagiline, selegiline, MAOis, linezolid, duloxetine, methylene blue, tizanidine, ramelteon, alosetron, agomelatine, bromopride, dapoxetine, tamsimelteon, thioridazine, urokinase, pimozide. Dose-dependent: SSRI, SNRI, tricyclic antidepressant, alprazolam, diazepam, theophylline, clozapine, olanzapine, NSAIDs, aspirin, warfarin, phenytoin, clopidrogrel, St. John’s wart, high-dose antipsychotic. Abbreviations: BMI, body mass index; CKD, chronic kidney disease; GFR, glomerular filtration rate; NSAIDs, nonsteroidal anti-inflammatory drugs; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; SNRI, serotonin and norepinephrine reuptake inhibitor; SSRI, selective serotonin reuptake inhibitors.